Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OMALIZUMAB Cause Blood thyroid stimulating hormone increased? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Blood thyroid stimulating hormone increased have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.0% of all adverse event reports for OMALIZUMAB.

14
Reports of Blood thyroid stimulating hormone increased with OMALIZUMAB
0.0%
of all OMALIZUMAB reports
0
Deaths
1
Hospitalizations

How Dangerous Is Blood thyroid stimulating hormone increased From OMALIZUMAB?

Of the 14 reports, 1 (7.1%) required hospitalization.

Is Blood thyroid stimulating hormone increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does OMALIZUMAB Cause?

No adverse event (9,736) Asthma (9,354) Urticaria (9,231) Off label use (9,199) Dyspnoea (8,323) Drug ineffective (6,747) Cough (5,926) Pruritus (5,224) Fatigue (5,053) Malaise (4,820)

What Other Drugs Cause Blood thyroid stimulating hormone increased?

LEVOTHYROXINE (3,171) PEMBROLIZUMAB (330) LENVATINIB (228) NIVOLUMAB (226) ALEMTUZUMAB (194) CABOZANTINIB S-MALATE (164) AMIODARONE (143) SUNITINIB MALATE (112) SOMATROPIN (91) ATORVASTATIN (71)

Which OMALIZUMAB Alternatives Have Lower Blood thyroid stimulating hormone increased Risk?

OMALIZUMAB vs OMAVELOXOLONE OMALIZUMAB vs OMBITASVIR OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS

Related Pages

OMALIZUMAB Full Profile All Blood thyroid stimulating hormone increased Reports All Drugs Causing Blood thyroid stimulating hormone increased OMALIZUMAB Demographics